1. Home
  2. REPL vs HCSG Comparison

REPL vs HCSG Comparison

Compare REPL & HCSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • HCSG
  • Stock Information
  • Founded
  • REPL 2015
  • HCSG 1976
  • Country
  • REPL United States
  • HCSG United States
  • Employees
  • REPL N/A
  • HCSG N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • HCSG Assisted Living Services
  • Sector
  • REPL Health Care
  • HCSG Health Care
  • Exchange
  • REPL Nasdaq
  • HCSG Nasdaq
  • Market Cap
  • REPL 851.0M
  • HCSG 838.4M
  • IPO Year
  • REPL 2018
  • HCSG N/A
  • Fundamental
  • Price
  • REPL $9.00
  • HCSG $10.12
  • Analyst Decision
  • REPL Strong Buy
  • HCSG Buy
  • Analyst Count
  • REPL 6
  • HCSG 4
  • Target Price
  • REPL $20.00
  • HCSG $14.00
  • AVG Volume (30 Days)
  • REPL 658.1K
  • HCSG 489.7K
  • Earning Date
  • REPL 05-15-2025
  • HCSG 04-23-2025
  • Dividend Yield
  • REPL N/A
  • HCSG N/A
  • EPS Growth
  • REPL N/A
  • HCSG 2.57
  • EPS
  • REPL N/A
  • HCSG 0.53
  • Revenue
  • REPL N/A
  • HCSG $1,715,682,000.00
  • Revenue This Year
  • REPL $31.16
  • HCSG $6.49
  • Revenue Next Year
  • REPL N/A
  • HCSG $4.05
  • P/E Ratio
  • REPL N/A
  • HCSG $19.53
  • Revenue Growth
  • REPL N/A
  • HCSG 2.65
  • 52 Week Low
  • REPL $4.92
  • HCSG $9.70
  • 52 Week High
  • REPL $17.00
  • HCSG $12.99
  • Technical
  • Relative Strength Index (RSI)
  • REPL 22.80
  • HCSG 38.72
  • Support Level
  • REPL $10.17
  • HCSG $10.12
  • Resistance Level
  • REPL $10.78
  • HCSG $10.76
  • Average True Range (ATR)
  • REPL 0.62
  • HCSG 0.27
  • MACD
  • REPL -0.19
  • HCSG -0.05
  • Stochastic Oscillator
  • REPL 0.00
  • HCSG 11.38

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

About HCSG Healthcare Services Group Inc.

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.

Share on Social Networks: